MrC's Smallcap Sweeps for Oct 2022

[Hallucigenia]

I think this is the best "we just don't care" RNS I've seen in a long time, from Russian gas company Novatek who are in the process of cancelling their listings in the West :

https://www.investegate.co.uk/pao-novat ... 45021655E/
"the Company has decided not to publish its financial statements and not to hold a teleconference with investors on the third quarter and the nine months 2022 financial results."

[MrContrarian]

Smallcap Sweep. 27-Oct-22
A hacksaw for hard news

Purplebricks (PURP) new CFO from Nov 1. Old one is thanked. [SP=13.89 Cap=42m]
DeepVerge (DVRG) gets long expected placing away at 2p, a 20% discount. £10m plus broker offer for £2.5m. With warrants at 3p. [SP=2.5 Cap=5m]
Merit (MRIT) sells Media, Events and Training operations of its Dods Political Engagement business fo £4.5m. Last FY adj EBITDA was £0.5m. [SP=38 Cap=9m]
CloudCoCo (CLCO) guides FY-Sept rev £24m+ (£8.0m) as a result of the previously announced acquisitions. 'Trading EBITDA' c.£1.0m (£745k). In line? [SP=0.99 Cap=7m]
Inspecs (SPEC) guides Q1-3 rev down 3% in $, up 4% in const currency. Will "delay the expansion of the existing Vietnamese factory and the investment in a new factory in Portugal until at least Q3 2023" due to lower order book. Weak demand expected in Q4 and H1'23. [SP=111.75 Cap=114m]
Velocys (VLS) improved cecarbonisation of US Reference Project. "The significant improvement in negative carbon intensity has the potential to increase future revenue for Bayou Fuels and enhance the attractiveness of the project for third party project funding." [SP=4.66 Cap=65m]
Made .com (MADE) gives up on selling itself, will continue to look to preserve value for its creditors and shareholders. [SP=0.54 Cap=2m]
Plant Health Care (PHC) guides FY-Dec rev over $11.3m, materially ahead of market expectations, due to increased investment in product promotion and in inventory. "The increased revenue growth this year makes us confident that we are on track to achieve revenue of $30 million by 2025 and achieve cash breakeven within our existing cash reserves." [SP=9 Cap=28m]
Newmark Security (NWT) guides FY-Apr (two Prime Ministers ago) rev up 8%. Loss? Cost control cut loss in H2. Outlook "returned to profitability and positive operating cashflows during the first five months of FY 2023, whilst also continuing to grow revenues." [SP=23.15 Cap=2m]
Foxtons (FOXT) Q3 rev up 25%. Guides FY-Dec ahead of mgmt expectations. [SP=28.85 Cap=89m]
Manx Financial (MFX) subsidiary Conister Bank applies for UK Branch banking licence. [SP=14.37 Cap=17m]
Franchise Brands (FRAN) guides FY-Dec rev and adj EPS ahead of mkt exp. Cites performance from the transformational acquisition of Filta and the continued strong momentum at Metro Rod. [SP=148.28 Cap=193m]
Alumasc (ALU) AGM stmt "trading in our continuing operations over the first quarter of the current financial year has remained robust". In line? [SP=141.36 Cap=51m]

In line: STB, FTC, HSP, HTG, PCIP, TNT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 28-Oct-22
What's not to LIKE? A warning,that's what.

Allergy Therapeutics (AGY) to resume UK manufacturing production in mid-November. Stoppage will cut rev by c.13-18% of market expectations of c. £80m. [SP=16.2 Cap=110m]
Likewise (LIKE) guides FY-Dec rev slightly above market expectations but profit miss due to unfavourable market conditions caused by the war, political instability in the UK and thehot summer. "Expects profit before tax margins to be below current expectations at c.2%." [SP=18.5 Cap=45m]
Bidstack (BIDS) fesses up to partner Azerion claiming it has the right to end agreement. BIDS had told some investors this already. "Azerion has no present entitlement to end its agreement with the Group...Contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected." [SP=2.7 Cap=25m]
Mattioli Woods (MTW) AGM stmt: "Against a backdrop of market volatility and proactive engagement from our advisers, we have seen sustained demand for advice from clients." Hikes final div to 17.8p (13.5p). [SP=586 Cap=300m]
Directa Plus (DCTA) first exclusive supply agreement, for its printed graphene textile Planar Thermal Circuit, in Latin America. No £££. [SP=88 Cap=58m]
Plant Health Care (PHC) Harpin αß has been registered for use as a fertiliser in France, the first in Europe. Product is "a powerful biostimulant, improving the yield and quality of crops". [SP=9.22 Cap=28m]
Iofina (IOF) executed all agreements with a new brine supply partner to construct its latest iodine plant, IO#9. Q3 production in line. [SP=21 Cap=40m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 31-Oct-22
Cropper eye-popper profit miss. Chill trills.

TP (TPG) rec offer of 2.25p (190% premium) from Science Gp. [SP=0.87 Cap=6m]
4GLOBAL (4GBL) £4m five yr contract " with a major sporting infrastructure project for a city in the Middle East." Expects c.£600k booked this FY. [SP=58.88 Cap=15m]
James Cropper (CRPR) guides FY-Mar adj pretax only £2m vs £5.4m f/c. H1-Sep rev up 26% but profit only breakeven due to inflation. "hows a recovery through aggressive pricing actions and surcharges, supported by the recently announced Government support on energy prices." [SP=1022 Cap=95m]
Equals (EQLS) extends option period for CEO "to bring them in line with its current incentive plans which have a standard ten-year option period". Ten years! [SP=89 Cap=161m]
Argo Blockchain (ARB) gives up on getting £24m subscription, continuing to explore other financing opportunities. Opportunities! Hah! If no funding found co will be "cash flow negative in the near term and would need to curtail or cease operations." Sells more mining machines that co hasn't even got out of the box. [SP=15.93 Cap=97m]
SIMEC Atlantis Energy (SAE) sells 79% of Advanced Tidal Engineering and Services division, which designs its turbines, for £0.5m plus £0.5m contingent. [SP=1.2 Cap=9m]
EQTEC (EQT) R&D facility successfully upgraded for hydrogen and renewable natural gas testing following "completion of steam-oxygen gasification tests that confirm the suitability of EQTEC's synthesis gas technology". [SP=0.28 Cap=27m]
Chill Brands (CHLL) AGM stmt. relaunched website rev £10k in a week. Boosted by marketing of course. Forgets to say the magic word 'curated'. [SP=2.52 Cap=6m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 23-Nov-22
What shall we do with a sunken failure?

Applied Graphene Materials (AGM) strategic review due to need for funds. May include raising additional funding from a specialist debt provider or strategic investor, sale of assets or company. [SP=5.27 Cap=3m]
booHoo (BOO) The Times reports poor conditions in warehouse https://www.thetimes.co.uk/article/booh ... -dspflp9cj [SP=38.81 Cap=492m]
Alliance Pharma (APH) guides FY-Dec rev only £170m+ and U/L pretax £30m+. Blames B2B market demand for Kelo-cote in China and destocking. "Confident that the B2B market for Kelo-cote will recover to pre-pandemic levels during 2023, which, combined with continued strong growth in B2C sales, leaves FY2023 Kelo-cote expectations unchanged." [SP=60.9 Cap=331m]
SourceBio (SBI) to delist. 115p tender offer for 15% of shares. Blames low SP, costs and illiquidity. [SP=105 Cap=78m]
Insight Business Support (KLSO) changes name to Kelso. £3m raise at 2p completed. [SP=NA Cap=NA]
Webis (WEB) WatchandWager license renewed for 2 yrs in California. [SP=1.24 Cap=5m]
Seeing Machines (SEE) Q1 KPIs. Aftermarket sales slow due to previously reported supply constraints. Also "rate of connections has also been slower than hoped as our customers deal with timing of supply and effects of the pandemic". Encouraging signs of a return to a more normalised growth rate. [SP=6.98 Cap=289m]

In line: DPEU, DIA, BOTB, EAH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 24-Nov-22
Dreams shatter at DeepMatter. Blow to HEAD.

Time Out (TMO) €35m new secured loan note facility at 9.5% plus 3-month EURIBOR. [SP=37 Cap=126m]
Ince (INCE) £4.7m placing at 6p, a 5% premium, for growth. [SP=5.98 Cap=15m]
Surface Transforms (SCE) Big order but a dab on the brakes this FY. OEM10 places 6 yr order worth over £100m. Expects series production revenues starting in H1 2025. Cuts FY22 rev exp to £6.5m and profit by £3m due to technical issues at OEM 8 unrelated to its discs, delaying sales by a few months. SCE's own production problems means it "could not offer OEM 8 more than our previous commitments until the new £50m p.a. plant comes on stream in Q2 2023." [SP=41 Cap=99m]
DeepMatter (DMTR) proposes delisting "to provide greater opportunities to raise additional capital". Will raise c.£1m from its major shareholders ahead of the delisting. Guides FY rev £1.5m+. [SP=0.11 Cap=4m]
Michelmersh Brick (MBH) guides FY-Dec rev and profit ahead of market expectations. [SP=79 Cap=76m]
Headlam (HEAD) guides FY-Dec U/L profit marginally below the low end of the range of market expectations due to weak residential demand. [SP=291 Cap=243m]
Cambridge Cognition (COG) expansion in the Chinese market through a strategic partnership with Luca Healthcare. COG will be paid through a mix of milestone payments and royalties. [SP=118 Cap=37m]
TClarke (CTO) guides FY-Dec rev c.£410m with c.£40m delayed to FY23. Operating margins (EBIT) c.2.8% and EPS up 27%. "We remain on track to deliver our strategic target of £500m revenue in 2023." [SP=124.81 Cap=55m]

In line: ENSI, GTLY, MACF
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

ignore